论文信息 - Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306) - 字舞流文

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

P. Nyirjesy | M. Ghannoum | R. Sobel | J. Sobel | K. Borroto-Esoda | N. Azie | J. Sobel | D. Angulo | I. A. Harriott | M. Ghannoum | D. Delchev | NE Azie | IA Harriott | Dimitar A Delchev | Ryan H. Sobel